Jennifer Wargo

Feb 7, 2024 | nature.com | Bin Fang |Michael White |John M. Koomen |Jennifer Wargo |Jianfei Qi

AbstractMelanoma incidence and mortality rates are historically higher for men than women. Although emerging studies have highlighted tumorigenic roles for the male sex hormone androgen and its receptor (AR) in melanoma, cellular and molecular mechanisms underlying these sex-associated discrepancies are poorly defined.

Oct 14, 2023 | healio.com | Mindy Valcarcel |John D. Carpten |Lisa Newman |Jennifer Wargo

You've successfully added Hematology Oncology: Breast Cancer to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The National Academy of Medicine announced the election of 90 regular members and 10 international members.

Aug 10, 2023 | africa.isp.msu.edu | Jennifer Wargo

This article's original translation into Chinese was written by Adele Han. Asia Hub wrapped up its international annual meeting in July 2023, held in Sanya, Hainan, China. This event was organized by Michigan State University (MSU), Nanjing Agricultural University (NAU), Sanya Yazhou Bay Science and Technology City Administration, Future Earth Nexus KAN, and the Sanya Institute of Nanjing Agricultural University.

Jul 12, 2023 | cell.com | Manoj Chelvanambi |Jennifer Wargo

• None Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. :• None Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1. :• None Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer. :• None Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.

May 3, 2023 | nature.com | Joon Seok Park |SArah Johnson |Sarah Johnson |Golnaz Morad |Stephanie S. Watowich |Jennifer Wargo | +3 more

AbstractThe gut microbiota is a crucial regulator of anti-tumour immunity during immune checkpoint inhibitor therapy. Several bacteria that promote an anti-tumour response to immune checkpoint inhibitors have been identified in mice1,2,3,4,5,6. Moreover, transplantation of faecal specimens from responders can improve the efficacy of anti-PD-1 therapy in patients with melanoma7,8.